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Summary  18 
Campylobacter jejuni and Campylobacter coli are zoonotic pathogens once considered 19 
asaccharolytic, but are now known to encode pathways for glucose and fucose 20 
uptake/metabolism. For C. jejuni, strains with the fuc locus possess a competitive advantage in 21 
animal colonization models. We demonstrate that this locus is present in >50% of genome-22 
sequenced strains and is prevalent in livestock-associated isolates of both species. To better 23 
understand how these campylobacters sense nutrient availability, we examined biofilm formation 24 
and chemotaxis with fucose. C. jejuni NCTC11168 forms less biofilms in the presence of fucose, 25 
although its fucose permease mutant (fucP) shows no change. In a newly developed chemotaxis 26 
assay, both wild-type and the fucP mutant are chemotactic towards fucose. C. jejuni 81-176 27 
naturally lacks the fuc locus and is unable to swim towards fucose. Transfer of the NCTC11168 28 
locus into 81-176 activated fucose uptake and chemotaxis. Fucose chemotaxis also correlated 29 
with possession of the pathway for C. jejuni RM1221 (fuc+) and 81116 (fuc-). Systematic 30 
mutation of the NCTC11168 locus revealed that Cj0485 is necessary for fucose metabolism and 31 
chemotaxis. This study suggests that components for fucose chemotaxis are encoded within the 32 
fuc locus, but downstream signals, only in fuc+ strains, are involved in coordinating fucose 33 
availability with biofilm development.  34 
 35 
 36 
 37 
 38 
 39 
Introduction  40 
Campylobacter infections, caused primarily by C. jejuni or C. coli, are among the leading causes 41 
of bacterial foodborne diarrheal disease (Allos, 2001; Silva et al., 2011) and are associated with 42 
the development of Guillian-Barré syndrome and its variants (Taboada et al., 2007; Keithlin et 43 
al., 2014). C. jejuni and C. coli were previously considered to be asaccharolytic and rely on other 44 
carbon and nitrogen sources, such as amino acids and intermediates of the citric acid cycle for 45 
growth (Velayudhan and Kelly, 2002; Stahl et al., 2012; Szymanski and Gaynor, 2012; 46 
Hofreuter, 2014). Recently, this dogma was challenged when C. jejuni NCTC11168 was reported 47 
to possess a fuc locus (cj0480c-cj0490) which encodes Cj0486, an L-fucose permease 48 
responsible for fucose transport across the inner membrane (FucP), and Cj0480c, the fucose 49 
operon repressor (FucR) along with other annotated, but uncharacterized genes required for L-50 
fucose metabolism described in Table 1 (Muraoka and Zhang, 2011; Stahl et al., 2011). 51 
Furthermore, it was recently shown that certain C. coli isolates possess the ability to transport 52 
and metabolize glucose (Vorwerk et al., 2015).  53 
Fucose is found in human and chicken mucin (Macfarlane et al., 2005; Stahl et al., 2011), on 54 
epithelial cell surfaces (Becker and Lowe, 2003; Pickard et al., 2014; Wacklin et al., 2014) and 55 
in our diet (Chaturvedi et al., 2001; Chow and Lee, 2008; Zivkovic and Barile, 2011). C. jejuni 56 
binds to fucosylated structures (Ruiz-Palacios et al., 2003; Day et al., 2009) and this binding is 57 
inhibited by fucose-containing structures, such as fucosylated human milk oligosaccharides 58 
(Cervantes et al., 1996; Ruiz-Palacios et al., 2003; Newburg et al., 2005; Weichert et al., 2013). 59 
Furthermore, the presence of L-fucose offers an advantage to C. jejuni NCTC11168 by 60 
enhancing its growth in laboratory media (Muraoka and Zhang, 2011; Stahl et al., 2011) and 61 
providing the wild-type with a competitive advantage in the piglet model of human disease over 62 
a fucP mutant (Stahl et al., 2011). The wild-type also outcompetes the fucP mutant at low 63 
infection doses in chickens fed with a fucose rich diet (Muraoka and Zhang, 2011). These 64 
findings suggest an important role for fucose binding, uptake and metabolism in Campylobacter 65 
host colonization and pathogenesis.  66 
Chemotaxis also plays an important role in the pathogenicity of C. jejuni. Mutants in the 67 
chemotaxis signal transduction pathway (che) are less virulent and exhibit reduced colonization 68 
in chicken and mouse colonization models (Hendrixson and DiRita, 2004; Chang and Miller, 69 
2006), in addition to showing attenuation in the ferret disease model (Yao et al., 1997). 70 
Interestingly, L-fucose is the only carbohydrate chemoattractant for C. jejuni (Hugdahl et al., 71 
1988) and chemotaxis mutants, such as cheA (Reuter and van Vliet, 2013), do not swim towards 72 
this sugar.   73 
Biofilm formation is also associated with persistence and infection in several bacteria such as 74 
Pseudomonas aeruginosa, Streptococcus pneumonia and enteropathogenic Escherichia coli 75 
(Costerton et al., 1999; Hall-Stoodley et al., 2004; Aparna and Yadav, 2008; Hall-Stoodley and 76 
Stoodley, 2009). C. jejuni forms biofilms on epithelial cells (Haddock et al., 2010) and on abiotic 77 
surfaces (Trachoo et al., 2002; Kalmokoff et al., 2006; Sanders et al., 2008; Gunther and Chen, 78 
2009; Nguyen et al., 2010; Moe et al., 2010; Maal-Bared et al., 2012) and is affected by multiple 79 
environmental factors. For example, C. jejuni biofilm growth is reduced in the presence of NaCl 80 
and sucrose, and this is attributed to the osmotic stress induced by these compounds (Reeser et 81 
al., 2007). In addition, nutrient rich media, such as Brucella and Bolton broth, inhibit biofilms 82 
(Reeser et al., 2007) while the presence of organic materials and biofouling can increase biofilm 83 
formation (Brown et al., 2014). Temperature and oxygen tension also alter biofilm densities 84 
(Reeser et al., 2007; Reuter et al., 2010). C. jejuni mutants with defects in biofilm formation 85 
show reduced chicken colonization and, adhesion and invasion of epithelial cells, as well as 86 
reduced intracellular survival (Svensson et al., 2009; Theoret et al., 2011; Theoret et al., 2012; 87 
Rahman et al., 2014).  88 
In this study, we investigated the influence of the fuc locus on biofilm development and 89 
chemotaxis by C. jejuni NCTC11168. Biofilm formation by the wild-type is reduced in the 90 
presence of L-fucose, but remains unaltered in a fucP mutant. Transfer of the fuc locus genes 91 
(cj0481-cj0490) from NCTC11168 into the fuc locus deficient strain, 81-176, allowed the 92 
recombinant strain to actively transport L-fucose and enhanced its growth in the presence of this 93 
carbohydrate. Interestingly, we found that both C. jejuni NCTC11168 wild-type and the fucP 94 
mutant are chemotactic towards L-fucose and the transfer of the locus into 81-176 also triggered 95 
a positive chemotactic response towards this carbon source. The observed correlation between 96 
possession of the fuc locus and chemotaxis towards this carbon source allowed us to identify a 97 
product of the pathway, Cj0485 that links fucose metabolism and chemotaxis.  98 
 99 
Results 100 
Distribution of the fuc locus in C. jejuni and C. coli genomes 101 
In our previous study, we reported that the fuc locus is present in C. jejuni strains NCTC11168, 102 
RM1221, CF93-6, 84–25, C. jejuni subsp. doylei 269.97, and C. coli RM2228, but absent in C. 103 
jejuni strains 81–176, CG8486, HB93-13, 260.94, and 81116 (Stahl et al., 2011). We have 104 
determined the prevalence of the fuc locus (cj0480c-cj0490) in 4,232 C. jejuni and C. coli 105 
genome sequences, which were phylogenetically clustered using feature frequency profiling (van 106 
Vliet and Kusters, 2015). The fuc locus was present in 2,431 out of 3,746 C. jejuni genomes 107 
(64.9%) and 354 out of 486 C. coli genomes (72.8%) (Fig. 1, Table S1). The distribution of the 108 
fuc locus was associated with specific MLST-clonal complexes, such as ST-21, ST-48, ST-206, 109 
ST-354 and ST-257 in C. jejuni¸ while MLST-clonal complexes such as ST-45, ST-283, ST-42, 110 
ST-353 and ST-464 are mostly lacking the fuc locus (Fig. 1). In C. coli, the fuc locus was 111 
primarily found in the MLST-clonal complex ST-828, but not in the riparian isolates (Sheppard 112 
et al., 2013). Livestock-associated (agricultural) lineages are shown in red whereas water and 113 
wildlife-associated (environmental) lineages are shown in blue in Fig. 1 (Stabler et al., 2013). 114 
Interestingly, there appears to be a trend toward agriculture isolates possessing the pathway and 115 
environmental isolates lacking this pathway (Fig. 1), although the data set is currently skewed 116 
toward agriculture isolates linked with human infections. 117 
L-fucose modulates biofilm formation in C. jejuni NCTC11168  118 
We investigated biofilm formation in the presence of 25 mM L-fucose in static glass tube 119 
cultures. We found that addition of L-fucose to the MH culture medium caused an approximately 120 
2-fold reduction in the amount of biofilm formed by wild-type C. jejuni NCTC11168 as 121 
determined by the absorbance at 570 nm via the crystal violet staining method (Fig. 2). The 122 
reduction was significantly different in a paired student’s t-test (p-value <0.05) (Fig. 2). 123 
Previously, a mutation in the fucose permease, fucP in this strain has been shown to inactivate L-124 
fucose uptake from the extracellular environment (Muraoka and Zhang, 2011; Stahl et al., 2011). 125 
We found that biofilm formation by the fucP mutant in the presence of fucose was similar when 126 
compared to unsupplemented medium. To show that the observed biofilm change was specific to 127 
L-fucose, we assayed biofilm formation in the presence of 25 mM D-galactose. Biofilm 128 
formation by the wild-type and fucP mutant in media supplemented with D-galactose was not 129 
significantly different when compared to the amount of biofilm formed in unsupplemented media 130 
(Fig. 2). Our results also demonstrate that the amount of biofilm formation in unsupplemented 131 
media by wild-type C. jejuni and the fucP mutant are similar (Fig. 2). The fucose repressor 132 
mutant, fucR exhibited a phenotype similar to wild-type and showed reduction in biofilm 133 
formation in medium supplemented with 25 mM L-fucose (Fig. S1). 134 
We further investigated the effects of L-fucose on the appearance and architecture of biofilms by 135 
scanning electron microscopy (SEM). We analysed both C. jejuni NCTC11168 wild-type and 136 
fucP mutant biofilms that had formed on glass slides in MH or MH with 25 mM L-fucose. Wild-137 
type C. jejuni formed thick biofilms in the absence of 25 mM L-fucose (Fig. 3).  These biofilms 138 
had a very dense mass of cells comparable to previous observations of C. jejuni biofilms (Joshua 139 
et al., 2006; Brown et al., 2014) (Fig. 3). Interestingly, biofilm formation was severely reduced 140 
when cells were grown in the presence of 25 mM L-fucose with only a few C. jejuni detectable 141 
on the glass slide (Fig. 3). In contrast, biofilm formation by the fucP mutant appeared similar in 142 
density and architecture in the presence or absence of fucose. Biofilms formed by the fucP 143 
mutant were also comparable to wild-type biofilms grown in the absence of L-fucose (Fig. 3). 144 
No biofilms were detected in the negative control samples. Our SEM analysis was consistent 145 
with the results obtained from the crystal violet staining assay. 146 
Transfer of the fuc locus from C. jejuni NCTC11168 into C. jejuni 81-176  147 
C. jejuni 81-176 naturally lacks the fuc locus (Table S1) (Stahl et al., 2011). A plasmid 148 
containing cj0481 to cj0490 was constructed and transferred into 81-176 resulting in 81-149 
176Ωfuc. To test the functionality of the fuc locus on the introduced plasmid, the uptake rates of 150 
3H-L-fucose by 81-176Ωfuc were determined in cells grown in the presence or the absence of 151 
fucose and compared to wild-type 81-176 and NCTC11168 that were grown under similar 152 
conditions. Wild-type NCTC11168 showed basal 3H-L-fucose uptake rates (3.3 pmol 3H-L- 153 
fucose/min/109 cfu) when grown in MH alone (Fig. 4A). [3H]-L-fucose uptake rates significantly 154 
increased (around 4-fold to 12.0 pmol 3H-L-fucose/min/109 cfu) when wild-type cells were 155 
grown in the presence of fucose demonstrating the induction of the system in the presence of its 156 
substrate (Fig. 4A). 157 
In contrast, no 3H-L-fucose transport was observed in 81-176 in the presence of fucose in the 158 
growth medium consistent with the absence of the fucose locus in this strain. (Fig.4A). 159 
Interestingly, 81-176Ωfuc exhibited significantly higher uptake rates of 3H-L-fucose independent 160 
of the presence or absence of fucose in the growth medium prior to the addition of 3H-L-fucose 161 
(34.8 pmol 3H-L-fucose/min 109 cfu and 36.5 pmol 3H-L-fucose/min/109 cfu, respectively), 162 
indicating that the pathway is constitutively expressed in this strain (Fig. 4A). Analysis of growth 163 
rates further demonstrated that C. jejuni 81-176 wild-type is unable to utilize L-fucose for 164 
enhanced growth. Growth curves and final OD600 were similar in the presence or absence of this 165 
carbon source (Fig. 4B). In contrast, the C. jejuni 81-176Ωfuc strain grown in the presence of L-166 
fucose showed significantly enhanced growth when compared to growth in MEM alone (Fig. 4B) 167 
(p-value <0.05). Similarly, wild-type C. jejuni NCTC11168 showed significant enhanced growth 168 
in MEM+L-fucose compared to MEM alone (Fig. 4B).  169 
We also examined biofilm formation by C. jejuni 81-176 and 81-176Ωfuc and observed that 170 
biofilm formation in both strains was unaffected by supplementation with L-fucose. D-galactose 171 
was included as another carbohydrate control and did not affect biofilm formation in these strains 172 
(Supplementary Fig. 1). 173 
Quantitative reverse transcriptase PCR (RT-PCR) was used to compare transcript levels of fucP 174 
in C. jejuni NCTC11168 and 81-176Ωfuc. FucP expression was significantly higher when C. 175 
jejuni NCTC11168 cells were grown in the presence of fucose compared to cells grown in 176 
unsupplemented MEM medium (Fig. 4C). Elevated fucP transcripts were detected at comparable 177 
levels when C. jejuni 81-176Ωfuc was grown in MEM alone or in MEM+L-fucose (Fig. 4C). 178 
This indicates that the pathway is constitutively expressed in C. jejuni 81-176Ωfuc and supports 179 
the observed increase and constitutive 3H-L-fucose uptake rates in this strain. We conclude that 180 
the fuc locus is fully functional in 81-176Ωfuc and results in increased uptake of L-fucose and 181 
enhanced growth. 182 
Identification of fucose utilization genes that play important roles in enhanced growth of C. 183 
jejuni in L-fucose 184 
We also tested whether mutations in the C. jejuni NCTC11168 fucose utilization genes cj0484, 185 
cj0485 and cj0488 affect growth in MEM alone or in MEM supplemented with L-fucose (Fig. 5), 186 
while other mutants in this locus have been previously analysed (Stahl et al., 2011). In agreement 187 
with previous observations, the wild-type strain showed approximately 2-fold enhanced growth 188 
in MEM supplemented with L-fucose (p-value <0.05) whereas the fucP mutant showed similar 189 
growth in MEM regardless of fucose addition (Fig. 5) (Muraoka and Zhang, 2011; Stahl et al., 190 
2011). We found that the cj0485 mutant did not show enhanced growth in the presence of L-191 
fucose and the OD600 was similar when compared to unsupplemented medium. However, growth 192 
was enhanced in the presence of L-fucose after complementation of the cj0485 mutation in trans. 193 
The cj0488 mutant behaved similar to wild-type (p-value <0.05) (Fig. 5). The cj0484 mutant also 194 
showed enhanced growth in the presence of fucose, however this increase was not significantly 195 
different compared to growth in MEM alone (Fig. 5). To eliminate the possibility of downstream 196 
effects of the cj0485 mutation on cj0486 expression, we performed RT-PCR on fucP in the 197 
cj0485 mutant and we were able to confirm expression of fucP in this strain. 16s rRNA used as a 198 
control showed similar RNA levels in the samples (Fig. 5).  199 
The roles of the fuc locus in chemotaxis towards L-fucose 200 
To examine C. jejuni chemotaxis towards L-fucose, we initially used the PBS agar plate assay 201 
that is typically used for the analysis of chemotaxis in this species (Hugdahl et al., 1988; Khanna 202 
et al., 2006; Vegge et al., 2009; Baserisalehi and Bahador, 2011). However, this assay resulted in 203 
false positives when applied to our negative controls, chemotaxis and motility mutants, similar to 204 
that described in another study (Kanungpean et al., 2011).  205 
To circumvent these problems, we established and confirmed the reproducibility of a novel assay 206 
with chemotaxis (cheY) and flagellar mutants (flaA). We further validated our assay using the 207 
previously described C. jejuni NCTC11168 chemoattractants: L-serine, L-aspartate and L-fucose 208 
(Hugdahl et al., 1988; Vegge et al., 2009; Baserisalehi and Bahador, 2011) as well as PBS 209 
(solvent control) and L-histidine (a known non-attractant) as negative controls. The assays were 210 
set-up as described in Materials and Methods and in Fig. 6. No rings were observed in any tubes 211 
containing the flaA and cheY mutants (Fig.6 and Fig. S2). This indicated that our assay does not 212 
give false positives and had been established successfully. In addition, we only detected 213 
culturable C. jejuni in the top layer of the chemotaxis tubes that showed positive results 214 
indicating that no passive diffusion of cells occurred and that the presence of cells is due to 215 
active migration through the agar as a chemotactic response towards the added substrate (data 216 
not shown).  217 
We applied the assay to examine the chemotactic responses of the C. jejuni fucP mutant. Red 218 
rings were observed around the positive control compound L-serine. Red rings were also 219 
observed in the test tube containing L-fucose indicating that this strain is still chemotactic 220 
towards this compound (Fig. 6). Next we analysed the chemotactic responses of C. jejuni 81-176 221 
and C. jejuni 81-176Ωfuc. Interestingly, 81-176Ωfuc was strongly chemotactic towards L-fucose 222 
as indicated by dark red rings around L-fucose in the tube whereas no red rings near L-fucose 223 
were observed for the parent 81-176 (Fig. 6). Consistent with published reports, 81-176 was 224 
chemotactic towards L-serine (Hugdahl et al., 1988; Baserisalehi and Bahador, 2011; Reuter and 225 
van Vliet, 2013) and the recombinant strain, 81-176Ωfuc, showed a similar chemotactic 226 
behaviour towards this amino acid. To further investigate the correlation between the presence of 227 
the fuc locus and fucose chemotaxis, we analysed the chemotaxis responses of the fuc locus 228 
deficient strain C. jejuni 81116 and the fuc locus positive strain C. jejuni RM1221. We could 229 
show that strain RM1221 was chemotactic towards L-fucose while strain 81116 was not (Fig. 6), 230 
indeed suggesting a correlation between the presence of the fuc locus and the ability to swim 231 
towards L-fucose. In addition red rings were observed around L-serine with RM1221 cells, but 232 
not with 81116 cells (Fig. 6). No red rings were observed with PBS for all the tested strains. The 233 
unusual observation that 81116 was naturally not chemotactic towards L-serine was further 234 
verified with the conventional chemotaxis plate assay (Fig. S3). Here no measurable chemotactic 235 
response towards L-serine could be observed for 81116 whereas C. jejuni NCTC11168 showed a 236 
strong chemotactic response towards this compound.    237 
Next we investigated if the loss of specific fuc genes involved in L-fucose metabolism has an 238 
impact on the chemotaxis response towards L-fucose. Mutation in cj0481, cj0483, cj0484, 239 
cj0487, cj0488 and cj0490 did not affect the ability of C. jejuni to swim towards L-fucose or L-240 
serine (Fig. S2).  Interestingly, the cj0485 mutant completely lost the ability to swim towards L-241 
fucose (Fig. 6), but was still capable of swimming toward the L-serine positive control. This 242 
indicates that the cj0485 gene product is crucial for chemotaxis specifically towards L-fucose in 243 
C. jejuni NCTC11168. Upon complementation of the cj0485 gene in trans, the strain regained 244 
the ability to swim towards L-fucose (Fig. 6). In order to determine if chemotaxis towards L-245 
fucose is dependent on the metabolic breakdown product of Cj0485 or directly on the protein, we 246 
created the cj0484/cj0486 double mutant that is deficient in both annotated L-fucose transporters 247 
thereby eliminating any possibility of L-fucose uptake and metabolism. We still observed 248 
chemotaxis in this strain (Fig. S4), suggesting that metabolic intermediates are not involved in 249 
chemotaxis. 250 
We further examined whether a mutation in cj0485 affected biofilm formation in response to L-251 
fucose and observed that the cj0485 mutant behaved similar to the fucP mutant in the test tube 252 
assay. We found that this mutant formed biofilms regardless of the presence of L-fucose (Fig. 2). 253 
As expected, biofilm formation by the cj0485 mutant was also unaffected in the presence of D-254 
galactose (Fig. 2). Complementation of the mutant in trans did not show any differences. 255 
 256 
Discussion    257 
The L-fucose uptake and utilization locus (fuc, cj0480-cj0490) in C. jejuni NCTC11168 provides 258 
the strain with a competitive advantage in avian and animal colonization models (Stahl et al., 259 
2011; Muraoka and Zhang, 2011). From recent studies it is becoming apparent that C. jejuni and 260 
C. coli have lineage-specific distribution patterns of metabolic markers, such as the vitamin B5 261 
biosynthesis cluster (Sheppard et al., 2013) and the fuc locus investigated in this study. The 262 
distribution of the fuc locus was previously suggested to be restricted to specific multilocus 263 
sequence types of C. jejuni and C. coli (de Haan et al., 2012), and we have confirmed and 264 
extended these observations here using a large collection of genome sequences from these 265 
species. The fuc locus is nearly universally present in the clonal complexes ST-21, ST-48, ST-266 
206, ST-257 and ST-354, which includes the reference isolates NCTC11168 and RM1221 used 267 
in this study, whereas the fuc locus is absent in other major lineages such as ST-42, ST-45 and 268 
ST-283, which includes other reference isolates such as 81116 and 81-176 used here (Fig. 1, 269 
Table S1). In C. coli, the majority of ST-828 isolates are positive for the fuc locus, while the 270 
riparian C. coli isolates lack the locus. It is not completely clear what causes the distribution 271 
pattern of the fuc locus, as many of the positive and negative livestock-associated isolates share 272 
the agricultural space and hence should have the opportunity for acquisition by horizontal gene 273 
transfer or natural transformation. Hence there may be other factors which govern the 274 
acquisition, functionality and maintenance of the fuc locus, rather than random exchange by 275 
natural transformation, such as the availability of fucose.  276 
We found that the addition of L-fucose resulted in a 2-fold reduction in wild-type NCTC11168 277 
biofilm formation in the standard crystal violet assay, whereas inactivation of the fucose 278 
permease, fucP abolished this phenotype. This indicates that active uptake of L-fucose is 279 
necessary to sense this carbon source. Examination of wild-type and fucP biofilms by SEM 280 
analysis showed that the biofilm architecture was similar to previously published reports (Joshua 281 
et al., 2006; Kalmokoff et al., 2006; Brown et al., 2014), and showed a similar loss of biofilm 282 
formation with fucose, consistent with the crystal violet assay results. In many organisms, such 283 
as Escherichia coli and Pseudomonas aeruginosa, biofilm formation is tied to stress responses 284 
that can be induced by DNA damage, the presence of antibiotics at sub-inhibitory or high 285 
concentrations, and by extracellular metal ions (Landini, 2009). In C. jejuni, biofilm formation 286 
has been linked to extracellular stresses, such as oxidative and osmotic stress (Fields and 287 
Thompson, 2008; Svensson et al., 2009). This study demonstrates that C. jejuni is also capable of 288 
sensing nutrient availability and reacting by maintaining a larger proportion of cells in a 289 
dispersed planktonic state. In C. jejuni isolates that are capable of fucose uptake and metabolism, 290 
we propose that there exists an intracellular regulatory network that couples an external sensory 291 
response with biofilm formation. It is likely that the inability to uptake/metabolize L-fucose by 292 
the fucP mutant and starvation in the absence of L-fucose in the case of the wild-type in minimal 293 
media may trigger a stress response that leads to higher levels of biofilm formation. This is 294 
consistent with the findings that nutrient rich medium, such as Brucella and Bolton broth, inhibit 295 
C. jejuni biofilm formation (Reeser et al., 2007). The observed phenomenon may maintain C. 296 
jejuni in a planktonic lifestyle in the competitive environment of the intestinal tract, which may 297 
consequently cause enhanced infections and efficient spread during diarrheal disease.  298 
To further investigate the importance of the fuc pathway in C. jejuni, we transferred the fuc locus 299 
(cj0481-cj0490) from NCTC11168 into 81-176, a strain that is naturally fuc deficient. We found 300 
that the fuc pathway is functional in the recombinant strain and results in active uptake of L-301 
fucose. Since the fuc locus was expressed on a plasmid, the copy number of the fuc genes in 81-302 
176 would be higher than in NCTC11168. In addition, the fuc locus repressor, fucR (cj0480) 303 
(Stahl et al., 2011) was not included on the plasmid resulting in constitutive expression in 81-304 
176. This caused overall higher expression levels of the fuc genes in 81-176Ωfuc and 305 
consequently ~3.5 fold higher uptake of L-fucose in the recombinant strain compared to 306 
NCTC11168. However, similar to NCTC11168, L-fucose also enhanced the growth of the 81-307 
176Ωfuc strain indicating that the fuc locus encodes all the proteins that are required for uptake 308 
and metabolism of L-fucose. Interestingly, our results also indicate that 81-176 lacks the 309 
intracellular regulatory network to alter biofilm formation in response to L-fucose since this 310 
compound had no influence on biofilm formation in wild-type 81-176 or the 81-176Ωfuc 311 
recombinant strain (Fig. S1).  312 
To confirm that the constitutive expression and higher copy numbers of the fuc locus from a 313 
plasmid in strain 81-176 are not influencing the biofilm phenotype, we constitutively expressed 314 
the fuc genes in NCTC11168 by creating a fucR regulatory mutant.  The NCTC11168 fucR 315 
mutant showed a reduction in biofilm formation in the presence of fucose similar to the isogenic 316 
wild-type further supporting our proposal that isolates naturally expressing the fucose pathway 317 
also have coordinated sensing of this nutrient with biofilm formation.  318 
During the analysis of the fuc mutants in the growth studies, we found that the cj0485 mutant 319 
behaved like the fucP mutant and did not show enhanced growth in the presence of L-fucose 320 
indicating the product of this gene is involved in fucose metabolism. The complementation of the 321 
cj0485 gene in this mutant restored the phenotype supporting our hypothesis. This mutant had 322 
also lost the ability to reduce biofilm formation in the presence of L-fucose, similar to a fucP 323 
mutant that is unable to uptake the substrate (Stahl et al., 2011). However, this phenotype was 324 
not restored in complementation experiments possibly due to non-native levels of expression. 325 
We also investigated the role of the fuc pathway in the chemotaxis response of C. jejuni 326 
NCTC11168. We established a new assay that eliminates false positive observations that have 327 
been reported in previous studies (Hugdahl et al., 1988; Khanna et al., 2006; Vegge et al., 2009; 328 
Baserisalehi and Bahador, 2011). We confirmed that wild-type NCTC11168 is chemotactic 329 
towards L-fucose as described (Hugdahl et al., 1988; Reuter and van Vliet, 2013), and show that 330 
the fucP mutant is chemotactic towards L-fucose. This suggests that fucose uptake is not 331 
required for chemotaxis. 81-176 encodes a functional chemotaxis pathway (Yao et al., 1997) 332 
however it does not swim towards L-fucose. We found that the recombinant strain 81-176Ωfuc 333 
displayed a strong chemotaxis response towards L-fucose. We also discovered that the fuc locus 334 
positive strain RM1221 was motile towards L-fucose, while the fuc locus deficient strain 81116 335 
was not suggesting that components for fucose chemotaxis are encoded within the fuc locus. This 336 
led to the systematic analysis of the fuc mutants in the chemotaxis assay and the subsequent 337 
identification of cj0485 as a link between fucose metabolism and chemotaxis. The cj0485 mutant 338 
was unable to swim towards L-fucose, but complementing the gene in trans restored the 339 
phenotype. BlastP analysis of Cj0485 indicates that the protein is homologous to short chain 340 
dehydrogenase enzymes that are generally involved in metabolism of compounds such as 341 
carbohydrates, amino acids and lipids (Kavanagh et al., 2008; Bijtenhoorn et al., 2011). Recent 342 
findings have also implicated dehydrogenases in quorum sensing pathways in bacteria (Lord et 343 
al., 2014). It is possible that cj0485 encodes a protein that is involved in both fucose metabolism 344 
and sensing. The transducer-like proteins (Tlps), found in the cytoplasm and inner membrane of 345 
in C. jejuni, are responsible for chemotaxis signaling (Zautner et al., 2011). Type A Tlps transect 346 
the inner membrane to sense compounds in the periplasm whereas Types B and C receive 347 
cytoplasmic signals. Cj0485 does not have a predicted transmembrane domain and mutation of 348 
the fucose permeases does not result in a loss of chemotaxis, so we do not believe Cj0485 is a 349 
Tlp. However, the protein may be involved in coordinating the signal between Tlp-like proteins 350 
in the periplasm and the che pathway. Future research will focus on the characterization of this 351 
protein and its involvement in fucose chemotaxis.   352 
Chemotaxis plays important roles in the pathogenicity of C. jejuni. Chemotaxis mutants are 353 
defective in chicken colonization and attenuated in the ferret diarrheal disease model (Yao et al., 354 
1997; Hendrixson and DiRita, 2004). C. jejuni exhibits chemotaxis towards many amino acids, 355 
salts of organic acids and purified mucin (Hugdahl et al., 1988; Vegge et al., 2009); however, L-356 
fucose is the only carbohydrate that serves as a chemoattractant for this pathogen. Since C. jejuni 357 
binds to fucosylated structures (Day et al., 2009), the ability to sense fucose may be important 358 
for targeting sites for gut colonization which is inhibited by the addition of exogenous 359 
compounds such as fucosylated human milk oligosaccharides (Cervantes et al., 1996; Ruiz-360 
Palacios et al., 2003; Newburg et al., 2005; Weichert et al., 2013). Furthermore the ability to 361 
metabolize fucose may be linked to virulence due to the competitive advantage observed for 362 
fucose-utilizing strains in a disease model (Stahl et al., 2011) as well as the identification of fucP 363 
as a potential virulence factor (Javed et al., 2010) and its overrepresentation in hyperinvasive 364 
strains (Fearnley et al., 2008). These studies suggest that there may be a potential link between 365 
sensing and chemo-attraction towards L-fucose in C. jejuni thereby influencing pathogenicity. 366 
Fucose is highly abundant in the intestine and plays an important role in the virulence of 367 
intestinal pathogens such as Enterohaemorrhagic E. coli (EHEC) and Salmonella Typhimirium, 368 
(Robbe et al., 2004; Pacheco et al., 2012; Weichert et al., 2013; Wang et al., 2015). However, 369 
due to lack of secreted or surface exposed fucosidases, EHEC, S. Typhimirium, as well as C. 370 
jejuni, are most likely unable to release fucose from commonly found oligosaccharides (Pacheco 371 
et al., 2012). However, other members of the intestinal microbiota, such as Bacteroides 372 
thetaiotaomicron, possess multiple glycosidases and have been shown to provide free 373 
carbohydrates for EHEC, S. Typhimirium and Clostridium difficile resulting in increased 374 
pathogenicity (Pacheco et al., 2012; Ng et al., 2013; Tailford et al., 2015). Thus we predict that 375 
C. jejuni also scavenges fucose freed by microbiota-secreted fucosidases. 376 
In this study, we report that the gene cluster for fucose uptake and metabolism is widespread 377 
among campylobacters. We demonstrate that this pathway is necessary for chemotaxis towards 378 
fucose and that fucose uptake influences biofilm formation. The new phenotypes described in 379 
this study highlight the possible functions of the fuc locus in the persistence and severity of C. 380 
jejuni infections. Further investigations into fully characterizing the fuc locus may highlight 381 
potential targets for the treatment of Campylobacter infections, particularly if this pathway is 382 
associated with strains causing human infections. 383 
Experimental Procedures 384 
Strains, plasmids and growth conditions  385 
C. jejuni strains were grown in MH broth (DifcoTM), MEM (Gibco) or on MH agar plates at 37oC 386 
under microaerobic conditions (85% N2, 10% CO2, 5% O2). E. coli was grown on LB medium at 387 
37oC under aerobic conditions. If required, antibiotics were added to a final concentration of 25 388 
µg/mL for kanamycin and chloramphenicol, 100 µg/mL for trimethoprim and ampicillin, and 389 
12.5 µg/mL for tetracycline. If not stated otherwise, L-fucose was added to a final concentration 390 
of 25 mM. Growth analysis of strains in the presence or absence of L-fucose was performed as 391 
described in (Stahl et al., 2011). Plasmids and oligonucleotides used in this study are listed in 392 
Table S2. Growth assays were performed as described earlier (Stahl et al., 2011). 393 
Identification of the fuc locus in C. jejuni and C. coli genome sequences 394 
A total of 3,746 C. jejuni and 486 C. coli genome sequences were obtained from public 395 
collections such as the Campylobacter pubMLST website (http://pubmlst.org/campylobacter/) 396 
(Jolley and Maiden, 2010) and Genbank (http://www.ncbi.nlm.nih.gov/genome/browse/), and are 397 
listed in Table S1 with accession numbers and assembly status. Genomes were searched using 398 
MIST (Kruczkiewicz et al., 2013) and the BLAST+ (v2.28) suite with each individual gene of 399 
the C. jejuni NCTC11168 fucose locus (cj0480c-cj0490). Genes were considered to be present if 400 
matching ≥ 90% with the query sequence. The MLST-clonal complex designation was 401 
determined for all genomes using MIST, with the definition file provided by the Campylobacter 402 
pubMLST website. All genomes were provisionally annotated using Prokka (Seemann, 2014) 403 
and were also searched for the presence of the predicted proteins of the fuc locus using BLAST 404 
(Table S1). A phylogenetic tree of all genomes was constructed using Feature Frequency 405 
Profiling of whole genome sequences using a word length of 18 (van Vliet and Kusters, 2015), 406 
and the resulting tree was visualised using Figtree using the proportional setting for 407 
presentational purposes. 408 
Construction of the ΔcheY, ΔfucR, Δcj0484, Δcj0485, and Δcj0488 isogenic deletion mutants 409 
 410 
Construction of the isogenic deletion mutants was performed using the In-fusion Dry-down PCR 411 
cloning kit (Clontech). Briefly, the target gene plus flanking regions were amplified using 412 
Phusion Hot Start II High-Fidelity DNA polymerase (Thermo Scientific) and the corresponding 413 
primers (Invitrogen) listed in Table S2. The In-fusion Dry-down cloning kit was used to 414 
directionally clone the amplified gene product into BamHI (Invitrogen) digested pUC19. 415 
Subsequently, inverse PCR was performed to amplify pUC19 plus the flanking end regions and 416 
part of the target gene. A chloramphenicol antibiotic resistance cassette was directionally cloned 417 
into the inverse PCR product, disrupting the target gene. The final construct was sequenced to 418 
confirm the absence of point mutations and then naturally transformed into C. jejuni 419 
NCTC11168. Clones were selected for on chloramphenicol supplemented MH agar plates and 420 
positive colonies were confirmed by PCR. Construction of an isogenic C. jejuni NCTC11168 421 
fucR mutant was done as follows: a PCR reaction using chromosomal DNA of strain CjWM116a 422 
(C. jejuni, fucR::cm, Muraoka, 2011) was performed with oligonucleotides fucR-R and fucR-F. 423 
The obtained 1.4 kbp fucR::cm DNA fragment was purified and inserted into the chromosome of 424 
C. jejuni NCTC11168 by natural transformation. Clones were selected and confirmed as 425 
described above.  426 
Complementation of the Δcj0485 mutant strain 427 
The C. jejuni NCTC11168 cj0485 gene was amplified using Phusion Hot Start II High-Fidelity 428 
DNA polymerase (Thermo Scientific) and the corresponding primers (Invitrogen) listed in Table 429 
S2. The amplified cj0485 gene was directionally cloned into XbaI digested pRRK plasmid using 430 
the In-fusion Dry-down PCR cloning kit (Clontech). The pRRK+cj0485 construct was 431 
sequenced to confirm the absence of PCR-induced errors in the cj0485 gene. The final construct 432 
was naturally transformed into the C. jejuni NCTC11168 Δcj0485 mutant strain and successful 433 
transformants were selected for on MH plates containing chloramphenicol and kanamycin. 434 
Insertion of the cj0485 gene was confirmed by PCR. 435 
Biofilm assay  436 
Campylobacter cells were grown in 5 ml of MH broth with required antibiotics for 18 hrs at 437 
37oC under microaerobic conditions (85% N2, 10% CO2, 5% O2) with shaking. Cultures were 438 
adjusted to an OD600 of 0.05 and supplemented with 25 mM L-fucose or 25 mM D-galactose in 439 
MH broth. One millilitre of culture was subsequently added to borosilicate test tubes (13 x100 440 
mm, Fisher Scientific) and supplemented with either L-fucose, D-galactose or MH alone. Test 441 
tubes containing only MH broth or MH broth supplemented with either L-fucose or D-galactose 442 
were used as negative controls. The tubes were sealed and further incubated at 37oC under 443 
microaerobic conditions for five days without shaking. Cultures were removed and the tubes 444 
were stained by coating with 100 µl of 1% crystal violet in 95% ethanol for 20 minutes at room 445 
temperature. The crystal violet stain was rinsed off thoroughly with distilled water until the wash 446 
was clear. Biofilms were dislodged by adding 500 µl of 2% SDS in water and vortexing until a 447 
homogenous solution was formed. One hundred microlitres of the solution was transferred into a 448 
96-well plate and the absorbance at 570 nm was measured in a plate reader. The crystal violet 449 
absorbance of the negative control tubes was subtracted from the absorbance readings of the 450 
other samples. A student’s paired t-test analysis was performed using Excel software 451 
(Microscoft®) and a p<0.05 was considered statistically significant. 452 
 453 
Scanning electron microscope (SEM) of C. jejuni biofilms on glass  454 
Cells were grown as described above (biofilm assay). One millilitre of each culture with an 455 
OD600 of 0.05 was transferred into 24 well plates containing 10x20 mm glass slides (Thomas 456 
Scientific). After 5 days of incubation without shaking, supernatants containing planktonic cells 457 
were removed.  Biofilms formed on the glass slide were fixed with 2 mL of fixative reagent (2.5 458 
% glutaraldehyde, 2 % paraformaldehyde in 0.1 M phosphate buffer) at 4ᵒC until the samples 459 
were processed. The slides were washed three times for 10 min with 0.1 M phosphate buffer 460 
(PBS, pH7.5). The biofilm samples were sequentially dehydrated for 10 min in 50% ethanol, 461 
70% ethanol, 90% ethanol, 2 × 100% ethanol, 75:25 ethanol: hexamethyldisilazane (HMDS), 462 
50:50 ethanol: HMDS, 25:75 ethanol: HMDS, 100% HMDS and dried overnight in the fume 463 
hood. The slides were mounted on an SEM stub for coating with gold using a Nanotech 464 
SEMPrep 2 DC sputter coater. The EOL 6301F field emission scanning electron microscope was 465 
used for the SEM with a liquid nitrogen cooled lithium drifted silicon energy dispersive x-ray 466 
(EDX) detector with a Norvar window manufactured by PGT.  467 
Transfer of the fuc locus from C. jejuni NCTC11168 into 81-176 and analysis of [3H]-L-468 
fucose uptake 469 
The fuc locus spanning the genes cj0481 to cj0490 (but lacking, cj0480/fucR) was amplified 470 
from C. jejuni 11168 chromosomal DNA as follows: 3883 bp and 4964 bp fragments, both 471 
including a native EcoRI restriction site, were amplified from chromosomal DNA with primers 472 
CS618-CS619 and CS620-CS621 and Pfx polymerase (Invitrogen). Both fragments were 473 
digested with EcoRI and inserted into a three arm ligation reaction into plasmid pBluescriptKS+ 474 
linearized with EcoRV. Positive clones with insertion of the fuc operon in the orientation of the 475 
lacZ gene were confirmed by restriction analyses and named pBluescriptKS+ (fuc). Plasmid 476 
pBluescriptKS+ (fuc) was subsequently digested with EcoRV-XhoI and the 8633 bp DNA 477 
fragment (containing cj0481 to cj0490) was purified and inserted into the E. coli - 478 
Campylobacter shuttle vector pCE111-28 (Larsen et al., 2004) treated with the same enzymes. 479 
Formation of the correct ligation product was screened and confirmed by restriction analyses. 480 
Plasmid DNA from one positive clone was named pCE111-28 (fuc) and used to transform E. coli 481 
C600 (RK212.2).  E. coli C600 (RK212.2) (fuc) cells were used to conjugate the pCE111-28 482 
(fuc) plasmid into C. jejuni 81-176 wild-type cells as described (Yao et al., 1997). 483 
Chloramphenicol resistant colonies were selected on MH plates supplemented with 484 
chloramphenicol and the presence of the plasmid was confirmed after plasmid-DNA isolation 485 
from 81-176Ωfuc and restriction analyses. [3H]-L-fucose uptake was performed as described 486 
previously (Stahl et al., 2011) with strains C. jejuni NCTC11168, C. jejuni NCTC11168 fucP, C. 487 
jejuni 81-176 wt and C. jejuni 81-176Ωfuc. 488 
Reverse transcriptase PCR (RT-PCR) 489 
Analysis of fucP mRNA transcripts was performed as described by Muraoka and Zhang (2011) 490 
with primers Cj0486 RT For and Cj0486 RT Rev for amplification of cj0486 and 16s RT For and 491 
16s RT Rev (Table S2) for amplification of 16s rRNA internal control. 492 
Tube-based chemotaxis assay 493 
Chemotaxis assays were performed as follows: 500 µL of cells (2.8 mL per gram of cell pellet) 494 
in 0.4% PBS-agar were transferred to the bottom of a 2 mL Eppendorf tube and allowed to 495 
solidify for 30 min at room temperature. Samples were overlaid first with 100 µL of PBS agar 496 
that was allowed to set for 30 min, followed by 900 µL of 0.4% PBS agar and allowed to solidify 497 
for an additional 30 min at room temperature. A sterile piece of Whatman paper, soaked with 50 498 
µL of a 1 M solution of L- fucose, L-serine, or 1xPBS was placed on top and samples were 499 
incubated under microaerobic conditions for 72 hrs at 37ᵒC. Active bacterial cells that migrated 500 
through the upper layer of PBS-agar towards the compound added to the Whatman paper were 501 
visualised by adding 500 µL of 0.01% 2,3,5 triphenyltetrazolium chloride (TTC) in PBS. The 502 
respiratory dye TTC detects redox activity from active bacterial cells and results in formation of 503 
red rings of bacterial cells that are visible after 3-4 hr incubation under microaerobic conditions 504 
(Brown et al., 2013; Reuter and van Vliet, 2013). In addition, plating of the accumulated bacteria 505 
from the top layer of the agar confirmed the presence/absence of viable cells that migrated from 506 
the bottom of the tube towards the substrate on the top.  507 
Plate-based chemotaxis assay 508 
C. jejuni strains 81116 and 11168 were cultured under microaerobic conditions at 37˚C overnight 509 
in MH broth. Strains were centrifuged at 6000 rpm at 4˚C for 10 min and washed with 1X PBS. 510 
The strains were then centrifuged, resuspended to an OD600 of 2 and mixed at a 1:1 ratio with 511 
0.8% PBS agar (final concentration of OD600 of 1, 0.4% PBS agar). Fifteen millilitres of each 512 
strain was poured into Petri dishes and allowed to solidify. Six millimeter paper absorbancy 513 
disks soaked with 1 M L-serine or PBS (negative control) were placed on the surface of the agar. 514 
The strains were incubated for 24 hours under microaerobic conditions at 37˚C and the diameter 515 
of chemotaxis was measured (mm). 516 
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Table 1: Putative functions and mutant phenotypes of proteins encoded by the fucose locus 778 
 
Protein 
Number 
 
Putative Function 
Mutant Phenotype  
Reference Enhanced 
growth on 
fucose 
Biofilms 
with 
fucose 
Chemotaxis 
towards 
fucose  
Cj0480c fucose operon repressor / 
transcriptional regulator 
nd - yes This study 
Cj0481 dihydrodipicolinate synthase no nd yes Stahl et al. 2011; this study 
Cj0482 altronate hydrolase / 
dehydratase 
mutant has not been constructed N/A 
Cj0483 altronate hydrolase / 
dehydratase 
yes nd yes Stahl et al. 2011; this study 
Cj0484 MFS transporter limited nd yes* This study 
Cj0485 short chain dehydrogenase no + no This study 
Cj0486 MFS transporter no  + yes Stahl et al. 2011; this study 
Cj0487 amidohydrolase no nd yes Stahl et al. 2011; this study 
Cj0488 epimerase yes nd yes This study 
Cj0489 aldehyde dehydrogenase mutant has not been constructed N/A 
Cj0490 aldehyde dehydrogenase yes nd yes Stahl et al. 2011; this study 
nd: not determined; - no/low biofilm formation in the presence of fucose (similar to the wildtype); + normal biofilm 779 
formation in the presence of fucose. 780 
*only tested as double-mutant with cj0486 781 
 782 
Figure Legends 783 
Fig. 1. Prevalence of the fucose operon among 3,746 C. jejuni and 486 C. coli genomes. 784 
Genomes were phylogenetically clustered using FFPry feature frequency profiling with L=18 785 
(van Vliet & Kusters, 2015), and the resulting phylogenetic tree has been transformed using the 786 
"proportional" setting of Figtree for presentational purposes. The first row labeled 'fucose' 787 
indicated genomes possessing the fucose pathway, which are shown in red while those lacking 788 
the pathway are shown in black. The second bar shows the primary combinations of MLST 789 
clonal complexes for C. jejuni and C. coli, with red-labeled clonal complexes representing 790 
livestock-associated lineages, blue-labeled clonal complexes representing water/wildlife-791 
associated lineages as described by Stabler et al (2013), with the exception of ST-61 which has 792 
been described as livestock-associated in other studies (Kwan et al, 2008; Rotariu et al, 2009). 793 
The association of some clonal complexes such as ST-464 was not reported previously, and these 794 
are in black font. The lowercase letters indicate the approximate position of strains 81116 (a), 795 
81-176 (b), RM1221 (c) and NCTC11168 (d). 796 
 797 
Fig. 2. The effect of L-fucose on C. jejuni NCTC11168 biofilm formation A) Absorbencies of 798 
solubilized biofilm obtained from the crystal violet assay measured at 570 nm. P-value of <0.001 799 
obtained in a paired student’s t-test is indicated by an asterisk (*). The bars represent an average 800 
of technical triplicates and the data is representative of at least 6 biological replicates. Error bars 801 
indicate standard error. B) Test tubes with crystal violet stained biofilms formed under the 802 
indicated conditions, (-) indicates growth in MH broth alone, (F) indicates growth in MH broth 803 
in the presence of 25 mM L-fucose, (G) indicates growth in MH broth in the presence of 25 mM 804 
D-galactose.  805 
 806 
Fig. 3 Scanning electron microscopy of C. jejuni NCTC11168 biofilms on glass slides formed 807 
under the indicated conditions in MH broth at 1000x magnification. Negative control indicates 808 
MH broth with no bacterial cells.  The images are representative of three independent 809 
experiments. 810 
 811 
Fig. 4 Functional analysis of the C. jejuni NCTC11168 fuc locus (cj0481- cj0490) after transfer 812 
into C. jejuni 81-176. A) Uptake of [3H]- L-fucose in the indicated strains including C. jejuni 81-813 
176 and C. jejuni 81-176  (fuc). B) Growth of indicated strains in minimal essential medium in 814 
the presence (black bars) or absence of L-fucose (white bars). C) Reverse transcriptase PCR 815 
analysis of fucP in the indicated strains grown in minimal essential medium with (black bars) or 816 
without L-fucose (white bars). P-value of <0.05 in a student’s paired t-test is indicated by an 817 
asterisk. Bars indicate average value obtained from at least three independent experiments and 818 
error bars indicate standard error. 819 
 820 
Fig. 5 Growth analysis of indicated C. jejuni NCTC11168 wild-type and specific fuc mutant 821 
strains in minimal essential medium supplemented with (black bars) or without L-fucose (white 822 
bars). The bars represent values obtained from at least two independent experiments and error 823 
bars indicate standard error. A student’s paired t-test was performed and an asterisk represents a 824 
p-value < 0.05. The inset shows reverse transcriptase PCR (RT-PCR) of 16s rRNA and cj0486 825 
mRNA in the wild-type C. jejuni NCTC11168 strain and the indicated mutants. Negative control 826 
lane contains no mRNA.    827 
 828 
Fig. 6 Analysis of the chemotaxis response of the indicated C. jejuni strains. A) A schematic of 829 
the chemotaxis assay. B) Images of the chemotaxis assay tubes of the indicated strains after 830 
development with 0.01% TTC (2,3,5 triphenyltetrazolium chloride). The + and – signs indicate 831 
the presence or absence of chemotaxis towards the compounds. The images are representative of 832 
at least three independent experiments. 833 
Fig. 1. Prevalence of the fucose operon among 3,746 C. jejuni and 486 C. coli genomes. Genomes were 
phylogenetically clustered using FFPry feature frequency profiling with L=18 (van Vliet & Kusters, 2015), 
and the resulting phylogenetic tree has been transformed using the "proportional" setting of Figtree for 
presentational purposes. The first row labeled 'fucose' indicated genomes possessing the fucose 
pathway, which are shown in red while those lacking the pathway are shown in black. The second bar 
shows the primary combinations of MLST clonal complexes for C. jejuni and C. coli, with red-labeled 
clonal complexes representing livestock-associated lineages, blue-labeled clonal complexes representing 
water/wildlife-associated lineages as described by Stabler et al (2013), with the exception of ST-61 
which has been described as livestock-associated in other studies (Kwan et al, 2008; Rotariu et al, 2009). 
The association of some clonal complexes such as ST-464 was not reported previously, and these are in 
black font. The lowercase letters indicate the approximate position of strains 81116 (a), 81-176 (b), 
RM1221 (c) and NCTC11168 (d).
Fig. 2. The effect of L-fucose on C. jejuni NCTC11168 biofilm formation A) Absorbencies of solubilized 
biofilm obtained from the crystal violet assay measured at 570 nm. P-value of <0.001 obtained in a 
paired student’s t-test is indicated by an asterisk (*). The bars represent an average of technical 
triplicates and the data is representative of at least 6 biological replicates. Error bars indicate standard 
error. B) Test tubes with crystal violet stained biofilms formed under the indicated conditions, (-) 
indicates growth in MH broth alone, (F) indicates growth in MH broth in the presence of 25 mM L-
fucose, (G) indicates growth in MH broth in the presence of 25 mM D-galactose. 
Fig. 3. Scanning electron microscopy of C. jejuni NCTC11168 biofilms on glass slides formed under the 
indicated conditions in MH broth at 1000x magnification. Negative control indicates MH broth with no 
bacterial cells.  The images are representative of three independent experiments.
Fig. 4. Functional analysis of the C. jejuni NCTC11168 fuc locus (cj0481- cj0490) after transfer into C. 
jejuni 81-176. A) Uptake of [3H]- L-fucose in the indicated strains including C. jejuni 81-176 and C. jejuni 
81-176  (fuc). B) Growth of indicated strains in minimal essential medium in the presence (black bars) or 
absence of L-fucose (white bars). C) Reverse transcriptase PCR analysis of fucP in the indicated strains 
grown in minimal essential medium with (black bars) or without L-fucose (white bars). P-value of <0.05 
in a student’s paired t-test is indicated by an asterisk. Bars indicate average value obtained from at least 
three independent experiments and error bars indicate standard error.
Fig. 5. Growth analysis of indicated C. jejuni NCTC11168 wild-type and specific fuc mutant strains in 
minimal essential medium supplemented with (black bars) or without L-fucose (white bars). The bars 
represent values obtained from at least two independent experiments and error bars indicate standard 
error. A student’s paired t-test was performed and an asterisk represents a p-value < 0.05. The inset 
shows reverse transcriptase PCR (RT-PCR) of 16s rRNA and cj0486 mRNA in the wild-type C. jejuni 
NCTC11168 strain and the indicated mutants. Negative control lane contains no mRNA. 
Fig. 6. Analysis of the chemotaxis response of the indicated C. jejuni strains. A) A schematic of the 
chemotaxis assay. B) Images of the chemotaxis assay tubes of the indicated strains after development 
with 0.01% TTC (2,3,5 triphenyltetrazolium chloride). The + and – signs indicate the presence or absence 
of chemotaxis towards the compounds. The images are representative of at least three independent 
experiments.
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Fig. S1. Effect of L-fucose on biofilm formation by C. jejuni NCTC 11168 fucose repressor 
mutant (fucR) and 81-176.  A) Absorbances of solubilized biofilm obtained from the crystal 
violet assay measured at 570 nm. The bars represent an average of technical triplicates and error 
bars indicate standard error. B) Test tubes with crystal violet stained biofilms formed under the 
indicated conditions, (-) indicates growth in MH broth alone, (F) indicates growth in MH broth 
in the presence of 25 mM L-fucose, (G) indicates growth in MH broth in the presence of 25 mM 
D-galactose.  
 
 
 
 
 
 
 
 
 
  
  
 
Fig. S2. Chemotaxis results of C. jejuni NCTC 11168 fucose locus mutants that are not 
chemotactic towards fucose. The assay was performed as described in Figure 6. The + and – 
signs indicate the presence or absence of chemotaxis towards the compounds and images are 
representative of at least three independent experiments. 
  
  
 
Fig. S3. C. jejuni 81116 is not chemotactic towards serine. Plate-based (A) and tube-based (B) 
assays were performed using C. jejuni NCTC 11168 as a positive control as described in 
Materials and Methods. 
  
  
 
 
Fig. S4. Chemotaxis assay of the C.jejuni NCTC 11168 Δcj0484/Δcj0486 fucose permease 
double mutant. Chemotaxis to L-fucose was examined in this background to eliminate the 
possibility that fucose could enter through the alternate annotated permease. 
 
 
 
 
